Infleqtion, Inc. (NYSE: INFQ) (“Infleqtion” or the “Company”), a global leader in quantum computing and quantum sensing powered by neutral atom technology, today reported third-quarter 2026 revenue of $9.1 million, up 25% year over year, and maintained its 2026 revenue outlook of at least $45.1 million.

“We are building Infleqtion to lead in utility-scale quantum computing, and this quarter’s progress strengthens our confidence in that ambition,” said Matt Kinsella, CEO of Infleqtion. “Delivering 30 logical qubits is an important step on our technology roadmap. Alongside that progress, growth in our backlog and remaining performance obligations gives us confidence in a strong 2027 across computing and sensing, with computing becoming a meaningfully larger part of our business.”

Third Quarter and Recent Business Highlights

  • Met 2026 Target of 30 Logical Qubits: Infleqtion demonstrated 30 entangled logical qubits working together in a single computation on Sqale using 80 physical qubits. An AI-assisted discovery cut the physical gates needed for a key logical operation in half, reducing opportunities for errors as the Company works toward longer computations and 100 logical qubits in 2028.

  • Quantum Computers Operational in Japan and the U.K.: Infleqtion’s QPU powers Japan’s first operational full-stack neutral atom quantum computer under the country’s Moonshot program, joining Infleqtion’s deployed system at the U.K.’s National Quantum Computing Centre.

  • Expanded Computing Collaborations and Customer Application Work: Infleqtion announced collaborations with NVIDIA, Cisco and Riverlane to advance quantum networking, error correction and software integration, capabilities needed to scale quantum computers and support more demanding customer applications. Infleqtion also launched its Quantum Application Forum series in London, bringing together companies from financial services, energy, pharmaceuticals and other industries to explore quantum computing applications.

  • $20 Million NASA Expansion Contract Funds Next Stage of Quantum Gravity Development: Infleqtion is developing quantum gravity sensing hardware with the Jet Propulsion Laboratory for NASA’s Quantum Gravity Gradiometer Pathfinder program, bringing the cumulative value of Infleqtion’s contract to $40 million.

  • $12 Million Award Funds Deployable Quantum Spectrum System: The award funds engineering and validation of Infleqtion’s Quantum Spectrum system for a direction-finding application, which detects radio signals and determines their direction. Initial development targets defense platforms where conventional antenna size limits deployment, bringing direction-finding capabilities to smaller systems.

  • Tiqker Demonstrates Rugged Operation in U.S. Navy Exercises: Tiqker demonstrated sustained operation aboard RV Merlin under demanding maritime conditions. The demonstration supports future naval integration of GPS-independent precision timing for navigation, communications and other mission-critical systems.

Conference Call Details

The Company will host a conference call at 4:30 PM Eastern Time today to discuss financial results. The call will be webcast live on the Company’s Investor Relations website at https://ir.infleqtion.com/ in the News & Events section. An archived replay will be available shortly after the call.

Live Call

Domestic Dial-In: 1-877-869-3847

International Dial-In: 1-201-689-8261

Replay

Domestic Dial-In: 1-877-660-6853

International Dial-In: 1-201-612-7415

Access ID: 13763444

Webcast

Event URL: https://event.webcasts.com/starthere.jsp?ei=1779772&tp_key=8d863a1477

The replay will be available approximately three hours after the conclusion of the conference call through November 30, 2026.

Upcoming Speaking and Event Participation

  • November 15–20: Supercomputing, Chicago, IL

  • November 24: Piper Sandler Virtual Quantum Day

  • November 30–December 3: NVIDIA GTC DC, Washington D.C.

  • December 2: UBS Technology Conference, Scottsdale, AZ

  • December 7–11: Australian Institute of Physics Congress 2026, Sydney, Australia

  • December 8–10: Q2B, Chicago, IL

  • December 16: Craig-Hallum Quantum Event, virtual

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of federal securities laws, including the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, as amended. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking, including statements regarding our financial condition, the Company’s expected 2026 revenue, business strategy and plans, business outlook, customer demand, commercial opportunities, and market momentum. These forward-looking statements generally are identified by the words “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “forecast,” “future,” “intend,” “may,” “might,” “opportunity,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “strategy,” “strive,” “target,” “will,” or “would,” the negative of these words or other similar terms or expressions. The absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are based on Infleqtion’s current expectations, assumptions and projections as of the date of this release and are subject to risks and uncertainties that could cause actual results to differ materially and adversely. Such risks and uncertainties include, without limitation, those related to Infleqtion’s ability to recognize anticipated benefits of its business combination with Churchill Capital Corp X; Infleqtion’s ability to grow and manage growth profitably; Infleqtion’s financial and business performance; changes in Infleqtion’s strategy, future operations, financial position, prospects and plans; the implementation, market acceptance and success of Infleqtion’s business model, growth strategy and opportunities, and Infleqtion’s ability to commercialize our quantum computing technology; Infleqtion’s expectations with respect to market opportunity and market growth; the expected benefits of and ability to maintain and enter into new contracts, awards and other relationships, partnerships or collaborations with governments and government entities; Infleqtion’s ability to maintain our NYSE listing; the potential for Infleqtion’s quantum computing technology to achieve quantum advantage; the ability of Infleqtion’s products to meet government counterparties’ and customers’ technical requirements and compliance and regulatory needs; Infleqtion’s ability to achieve timing and product development milestones on our product roadmap; Infleqtion’s ability to attract and retain qualified employees and management; Infleqtion’s expectations regarding our ability to obtain and maintain intellectual property protection and not infringe on the rights of others; intense global competition in a nascent and volatile quantum technology industry; Infleqtion’s reliance on sales to government entities and large enterprises; identified material weaknesses in our internal control over financial reporting; risks related to export and import controls, trade sanctions, and government contracting; Infleqtion’s dependence on in-licensed intellectual property and government-funded research subject to federal march-in rights; Infleqtion’s future capital requirements and sources and uses of cash; Infleqtion’s ability to obtain funding for our operations and future growth; and the outcome of any known and unknown litigation and regulatory proceedings; and other risks and uncertainties described under the caption “Risk Factors” in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on March 31, 2026, subsequent quarterly reports on Form 10-Q and our other documents filed from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and we assume no obligation and do not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise unless required to do so under applicable law. We do not give any assurance that we will achieve our expectations.

Non-GAAP Financial Measures

This press release includes certain non-GAAP financial measures. Infleqtion believes these measures provide investors with additional insight into the underlying performance of the business. These non-GAAP financial measures should not be considered in isolation or as substitutes for the comparable GAAP measures. In addition, these non-GAAP financial measures may not be computed in the same manner as similarly titled measures used by other companies.

“Non-GAAP Cost of revenue” is defined as cost of revenue expense adjusted to exclude, when applicable, stock-based compensation.

“Non-GAAP R&D” is defined as research and development expense adjusted to exclude, when applicable, stock-based compensation.

“Non-GAAP SG&A” is defined as selling, general and administrative expense adjusted to exclude, when applicable, stock-based compensation, acquisition and integration costs, go-public transaction expenses and former executive release payment.

“Non-GAAP Loss from operations” is defined as loss from operations adjusted to exclude, when applicable, stock-based compensation, go-public transaction expenses, acquisition and integration costs, former executive release payment and impairment of assets and goodwill.

“Non-GAAP Net loss” is defined as net loss adjusted to exclude, when applicable, stock-based compensation, go-public transaction expenses, acquisition and integration costs, unrealized gain or loss on equity investment, change in fair value of contingent consideration, change in fair value of SAFE liabilities, former executive release payment and impairment of assets and goodwill.

See “Reconciliation of Non-GAAP Financial Measures” in this press release for reconciliations of these non-GAAP measures to the most directly comparable GAAP measures. Management believes that Non-GAAP Cost of revenue, Non-GAAP R&D, Non-GAAP SG&A, Non-GAAP Loss from operations and Non-GAAP Net loss provide useful information to investors because they facilitate an evaluation of Infleqtion’s underlying operating performance and period-to-period comparability by excluding certain items that management believes do not directly reflect the Company’s core operations or may not be indicative of recurring operating results. Management uses these non-GAAP measures, together with the corresponding GAAP measures, to assess the operating performance of the business.

About Infleqtion

Infleqtion, Inc. (NYSE: INFQ) is a global leader in quantum technology, delivering neutral atom solutions for quantum computing, networking, sensing, and security. With a product portfolio spanning quantum computers, quantum optical clocks, RF receivers, and inertial sensors, Infleqtion’s full-stack approach combines high-performance hardware with the company’s proprietary Superstaq quantum computing software platform. Infleqtion’s systems are already in use by the U.S. Department of War, NASA, the U.K. government, and in multiple collaborations with NVIDIA. Infleqtion, in collaboration with NVIDIA, published the world’s first demonstration of a materials science application using logical qubits. With operations in the U.S., Europe, and Asia, Infleqtion meets the demands of government and commercial customers across the space, defense, energy, finance and telecommunications sectors. For more information, visit Infleqtion.com or follow Infleqtion on LinkedIn, YouTube, and X.

Infleqtion, Inc.

Condensed Consolidated Statements of Operations and Comprehensive Loss

(Unaudited; in thousands, except share and per share amounts)

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

 

2026

 

 

 

2025

 

 

 

2026

 

 

 

2025

 

Total revenue

$

9,149

 

 

$

7,311

 

 

$

32,594

 

 

$

20,783

 

Total cost of revenue

 

10,270

 

 

 

3,611

 

 

 

29,013

 

 

 

12,862

 

Gross profit (loss)

 

(1,121

)

 

 

3,700

 

 

 

3,581

 

 

 

7,921

 

Research and development

 

11,486

 

 

 

4,846

 

 

 

34,112

 

 

 

15,324

 

Selling, general and administrative

 

22,031

 

 

 

5,989

 

 

 

68,169

 

 

 

18,023

 

Grant income

 

(159

)

 

 

(436

)

 

 

(1,332

)

 

 

(1,531

)

Loss from operations

 

(34,479

)

 

 

(6,699

)

 

 

(97,368

)

 

 

(23,895

)

Other income (expense):

 

 

 

 

 

 

 

Unrealized gain on equity investment

 

9,742

 

 

 

—

 

 

 

9,742

 

 

 

—

 

Interest income

 

5,289

 

 

 

780

 

 

 

13,512

 

 

 

1,855

 

Other, net

 

(231

)

 

 

(274

)

 

 

21

 

 

 

842

 

Total other income, net

 

14,800

 

 

 

506

 

 

 

23,275

 

 

 

2,697

 

Loss before income taxes

 

(19,679

)

 

 

(6,193

)

 

 

(74,093

)

 

 

(21,198

)

Income tax expense (benefit)

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

Net loss

$

(19,679

)

 

$

(6,193

)

 

$

(74,093

)

 

$

(21,198

)

Other comprehensive income (loss):

 

 

 

 

 

 

 

Unrealized gain (loss) on available-for-sale securities, net

 

(1,019

)

 

 

105

 

 

 

(2,096

)

 

 

105

 

Foreign currency translation

 

(83

)

 

 

(204

)

 

 

(323

)

 

 

190

 

Total other comprehensive income (loss)

 

(1,102

)

 

 

(99

)

 

 

(2,419

)

 

 

295

 

Comprehensive loss

$

(20,781

)

 

$

(6,292

)

 

$

(76,512

)

 

$

(20,903

)

Net loss per share attributable to common stockholders – basic and diluted

$

(0.09

)

 

$

(0.38

)

 

$

(0.39

)

 

$

(1.34

)

Weighted average shares used in computing net loss per share attributable to common stockholders – basic and diluted

 

225,169,501

 

 

 

16,369,143

 

 

 

188,061,219

 

 

 

15,791,879

 

Infleqtion, Inc.

Condensed Consolidated Balance Sheets

(in thousands, except share and per share amounts)

 

 

As of

 

September

30, 2026

(Unaudited)

 

December 31,

2025

Assets

 

 

 

Current Assets:

 

 

 

Cash and cash equivalents

$

51,890

 

 

$

11,694

 

Available-for-sale securities, current

 

426,825

 

 

 

34,318

 

Accounts receivable

 

8,421

 

 

 

9,543

 

Unbilled receivables

 

4,336

 

 

 

2,637

 

Inventories

 

7,786

 

 

 

4,299

 

Prepaid expenses and other current assets

 

7,722

 

 

 

10,036

 

Total current assets

$

506,980

 

 

$

72,527

 

Property and equipment, net

 

12,792

 

 

 

8,674

 

Operating lease right-of-use assets

 

15,573

 

 

 

4,923

 

Available-for-sale securities, non-current

 

81,307

 

 

 

17,157

 

Goodwill

 

9,315

 

 

 

9,315

 

Other assets

 

14,440

 

 

 

620

 

Total Assets

$

640,407

 

 

$

113,216

 

Liabilities, Convertible Redeemable Preferred Stock and Stockholders’ Equity (Deficit)

 

 

 

Current Liabilities:

 

 

 

Accounts payable

$

5,139

 

 

$

5,644

 

Accrued liabilities

 

45,413

 

 

 

8,923

 

Contract liabilities

 

7,504

 

 

 

6,871

 

Current portion of operating lease liabilities

 

501

 

 

 

1,076

 

Deferred consideration payable, current

 

—

 

 

 

471

 

Total current liabilities

$

58,557

 

 

$

22,985

 

Operating lease liabilities, net of current portion

 

16,411

 

 

 

4,074

 

Deferred consideration payable

 

—

 

 

 

—

 

Total Liabilities

$

74,968

 

 

$

27,059

 

Convertible Redeemable Preferred Stock:

 

 

 

Series Seed convertible redeemable preferred stock; $0.0001 par value per share

 

—

 

 

 

6,526

 

Series Seed II convertible redeemable preferred stock; $0.0001 par value per share

 

—

 

 

 

10,411

 

Series A convertible redeemable preferred stock; $0.0001 par value per share

 

—

 

 

 

36,658

 

Series B convertible redeemable preferred stock; $0.0001 par value per share

 

—

 

 

 

112,145

 

Series B-1 convertible redeemable preferred stock; $0.0001 par value per share

 

—

 

 

 

32,990

 

Series C convertible redeemable preferred stock; $0.0001 par value per share

 

—

 

 

 

71,733

 

Series C-1 convertible redeemable preferred stock; $0.0001 par value per share

 

—

 

 

 

26,351

 

Total Convertible Redeemable Preferred Stock

$

—

 

 

$

296,814

 

Stockholders’ Equity (Deficit):

 

 

 

Preferred stock: $0.0001 par value per share; 100,000,000 shares authorized; no shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively

 

—

 

 

 

—

 

Common stock: $0.0001 par value per share; 1,400,000,000 shares authorized; 226,036,030 and 17,449,020 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively

 

23

 

 

 

2

 

Additional paid-in capital

 

874,518

 

 

 

21,931

 

Accumulated deficit

 

(307,589

)

 

 

(233,496

)

Accumulated other comprehensive income (loss)

 

(1,513

)

 

 

906

 

Total Stockholders’ Equity (Deficit)

$

565,439

 

 

$

(210,657

)

Total Liabilities, Convertible Redeemable Preferred Stock and Stockholders’ Equity (Deficit)

$

640,407

 

 

$

113,216

 

Infleqtion, Inc.

Condensed Consolidated Statements of Cash Flows

(Unaudited; in thousands)

 

 

Nine Months Ended September 30,

 

 

2026

 

 

 

2025

 

Cash flows from operating activities

 

 

 

Net loss

$

(74,093

)

 

$

(21,198

)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

Depreciation and amortization expense

 

3,024

 

 

 

2,410

 

Stock-based compensation expense

 

31,296

 

 

 

2,660

 

Change in fair value of contingent obligation

 

1,508

 

 

 

—

 

Unrealized gain on equity investment

 

(9,742

)

 

 

—

 

Amortization of premiums and accretion of discounts on available-for-sale securities

 

(3,376

)

 

 

—

 

Other non-cash operating adjustments

 

176

 

 

 

110

 

Changes in operating assets and liabilities:

 

 

 

Accounts receivable

 

1,091

 

 

 

(399

)

Unbilled receivables

 

(1,713

)

 

 

660

 

Inventories

 

(3,487

)

 

 

(1,832

)

Prepaid expenses and other current assets

 

(2,865

)

 

 

812

 

Other assets

 

(165

)

 

 

(12

)

Accounts payable

 

(475

)

 

 

1,971

 

Accrued liabilities

 

35,000

 

 

 

(404

)

Contract liabilities

 

641

 

 

 

(335

)

Operating lease right-of-use assets

 

1,327

 

 

 

490

 

Operating lease liabilities

 

(460

)

 

 

(877

)

Net cash used in operating activities

 

(22,313

)

 

 

(15,944

)

Cash flows from investing activities

 

 

 

Purchases of available-for-sale securities

 

(620,067

)

 

 

(51,415

)

Maturities of available-for-sale securities

 

164,600

 

 

 

—

 

Purchase of non-marketable equity investment

 

(3,000

)

 

 

—

 

Purchases of property and equipment

 

(6,899

)

 

 

(1,212

)

Net cash used in investing activities

 

(465,366

)

 

 

(52,627

)

Cash flows from financing activities

 

 

 

Proceeds from issuance of Series C convertible redeemable preferred stock

 

—

 

 

 

49,225

 

Proceeds from stock options and warrant exercises

 

5,321

 

 

 

826

 

Proceeds from stockholder contribution

 

300

 

 

 

—

 

Payment of accrued issuance costs

 

—

 

 

 

(2,410

)

Payment of offering costs

 

(4,092

)

 

 

(1,021

)

Proceeds from Business Combination, net of redemptions

 

528,166

 

 

 

—

 

Payment of deferred cash consideration

 

(475

)

 

 

(1,425

)

Net cash provided by financing activities

 

529,220

 

 

 

45,195

 

Foreign currency translation

 

(411

)

 

 

323

 

Net increase (decrease) in cash and cash equivalents and restricted cash

$

41,130

 

 

$

(23,053

)

Cash, cash equivalents and restricted cash at beginning of period

$

11,894

 

 

$

48,142

 

Cash, cash equivalents and restricted cash at end of period

$

53,024

 

 

$

25,089

 

Infleqtion, Inc.

Reconciliation of Non-GAAP Financial Measures

(in thousands)

 

The following is a reconciliation of non-GAAP measures of Infleqtion, Inc. for the three and nine months ended September 30, 2026 and 2025:

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

2026

 

2025

 

2026

 

2025

Cost of revenue

$

10,270

 

$

3,611

 

$

29,013

 

$

12,862

Adjustments:

 

 

 

 

 

 

 

Stock-based compensation

 

2,166

 

 

66

 

 

5,004

 

 

267

Non-GAAP Cost of revenue

$

8,104

 

$

3,545

 

$

24,009

 

$

12,595

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

2026

 

2025

 

2026

 

2025

Research and development expense

$

11,486

 

$

4,846

 

$

34,112

 

$

15,324

Adjustments:

 

 

 

 

 

 

 

Stock-based compensation

 

1,653

 

 

96

 

 

8,887

 

 

284

Non-GAAP R&D

$

9,833

 

$

4,750

 

$

25,225

 

$

15,040

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

2026

 

2025

 

2026

 

2025

Selling, general and administrative expense

$

22,031

 

$

5,989

 

$

68,169

 

$

18,023

Adjustments:

 

 

 

 

 

 

 

Stock-based compensation

 

7,118

 

 

611

 

 

17,405

 

 

2,109

Acquisition and integration costs

 

874

 

 

—

 

 

2,346

 

 

2,000

Go-public transaction expenses

 

—

 

 

—

 

 

11,466

 

 

—

Former executive release payment

 

—

 

 

—

 

 

750

 

 

—

Non-GAAP SG&A

$

14,039

 

$

5,378

 

$

36,202

 

$

13,914

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

 

2026

 

 

 

2025

 

 

 

2026

 

 

 

2025

 

Loss from operations

$

(34,479

)

 

$

(6,699

)

 

$

(97,368

)

 

$

(23,895

)

Adjustments:

 

 

 

 

 

 

 

Stock-based compensation

 

10,937

 

 

 

773

 

 

 

31,296

 

 

 

2,660

 

Acquisition and integration costs

 

874

 

 

 

—

 

 

 

2,346

 

 

 

2,000

 

Go-public transaction expenses

 

—

 

 

 

—

 

 

 

11,466

 

 

 

—

 

Former executive release payment

 

—

 

 

 

—

 

 

 

750

 

 

 

—

 

Non-GAAP Loss from operations

$

(22,668

)

 

$

(5,926

)

 

$

(51,510

)

 

$

(19,235

)

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

 

2026

 

 

 

2025

 

 

 

2026

 

 

 

2025

 

Net loss

$

(19,679

)

 

$

(6,193

)

 

$

(74,093

)

 

$

(21,198

)

Adjustments:

 

 

 

 

 

 

 

Stock-based compensation

 

10,937

 

 

 

773

 

 

 

31,296

 

 

 

2,660

 

Acquisition and integration costs

 

874

 

 

 

—

 

 

 

2,346

 

 

 

2,000

 

Go-public transaction expenses

 

—

 

 

 

—

 

 

 

11,466

 

 

 

—

 

Unrealized gain on equity investment 1

 

(9,742

)

 

 

—

 

 

 

(9,742

)

 

 

—

 

Former executive release payment

 

—

 

 

 

—

 

 

 

750

 

 

 

—

 

Non-GAAP Net loss

$

(17,610

)

 

$

(5,420

)

 

$

(37,977

)

 

$

(16,538

)

 

Note 1 – Represents the increase in the carrying value of the Company’s investment in a privately held company resulting from an observable price change during the period.

 

Media gallery

About The Author